Epilepsy and Cranial nerve affection in a Patient with Wilson’s disease and Intracranial developmental venous anomaly; A Case Report
Objective: 1.present unusual and rare clinical presentations in the disease spectrum2.study Intracranial developmental venous anomalies (DVAs) presentations both clinically and radiologically in Wilson’s disease and their…Neurological worsening in patients undergoing treatment for Wilson disease: Frequency, causes and outcomes.
Objective: To study the pattern of neurological worsening (NW) in patients undergoing treatment for Wilson disease (WD). Background: WD is an inherited disorder of copper…Clinical and imaging deterioration of a mild case of Wilson’s disease after chelation therapy
Objective: To present a case of a mild wilson disease with neuropsychiatric features which showed clinical and also imaging deteriotation five months after the chelation…Clinical profile of Wilson’s disease at Yangon General Hospital, Myanmar
Objective: To evaluate clinical, biochemical and imaging profile of patients with Wilson's Disease (WD). Background: There was no reported case series of WD in Myanmar.This…Copper chelation efficacy of alginate/chitosan based D-penicillamine nanoparticles in rat model of non-Wilsonian brain copper toxicosis
Objective: To evaluate the copper (Cu) chelation efficacy of orally administered D-penicillamine loaded nanoparticles to that of conventional D-penicillamine therapy for 90 days in Wistar…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.